The five main components of Good Manufacturing Practice are commonly known as the 5 Ps: People, Products, Processes, Procedures, and Premises. These five pillars form the framework that regulatory agencies use when inspecting pharmaceutical, food, and other manufacturing facilities to ensure products are consistently safe and high quality. Each component covers a distinct area of operations, and weakness in any one of them can compromise the entire system.
People
People sit at the center of the other four components because every aspect of manufacturing depends on human execution, oversight, and decision-making. U.S. federal regulations require that every person involved in manufacturing, processing, packing, or holding a product must have the right combination of education, training, and experience to perform their assigned tasks. That applies equally to the operator running a machine and the supervisor overseeing an entire production line.
Training is not a one-time event. Regulations specify that it must be conducted on a continuing basis and frequently enough that employees stay current with requirements relevant to their role. Training covers both the specific operations an employee performs and the broader GMP principles that apply to their functions. Facilities also need an adequate number of qualified personnel, not just well-trained ones. Understaffing is itself a compliance issue because it increases the risk of errors and shortcuts.
Beyond qualifications, personnel are expected to follow strict hygiene and sanitation practices. Depending on the product, this can include protective apparel covering the head, face, hands, and arms to prevent contamination. Every person’s responsibilities should be documented in writing so there is no ambiguity about who is accountable for what.
Products
The product component covers everything from incoming raw materials to the finished item that reaches consumers. Every raw material must be sourced from qualified suppliers, tested against documented specifications, and approved before it enters production. This applies to active ingredients, packaging materials, and labeling alike.
Finished products must meet the standards laid out in a master formula, which specifies the identity, strength, quality, and purity the product is supposed to have. Inspectors review company evidence to confirm that products consistently hit those marks. Batch-level testing, stability studies, and in-process checks all fall under this pillar. If a product fails to meet its specifications at any stage, it must be investigated and either reprocessed under controlled conditions or rejected entirely.
Processes
Processes are the repeatable activities that ensure consistency and quality throughout manufacturing. A process might be mixing a formulation, sterilizing equipment, or packaging finished goods. The key word is “repeatable.” If you can’t do it the same way every time and get the same result, the process isn’t under control.
Process validation is how manufacturers prove that a process reliably produces the intended outcome. This involves running the process under defined conditions and documenting that the results meet specifications across multiple batches. Cleaning validation is a specific and heavily scrutinized subset: manufacturers must demonstrate that equipment is cleaned to a level where residues are documented as safe and cause no quality concerns. The FDA has made clear that surface testing with a direct method is expected whenever feasible, rather than relying on rinse samples alone.
Processes are governed by standard operating procedures, which bridges this component directly into the next one.
Procedures
Procedures are the official, verified, and documented instructions that tell people exactly how to perform each task. Standard operating procedures (SOPs) are the backbone of this component. They provide step-by-step guidance for operational tasks and should be clear, concise, and logically structured, using headings, tables, and diagrams to improve readability.
Documentation goes well beyond SOPs. GMP requires that records be created at the time each action is taken, not after the fact, so that every activity related to development, manufacturing, and testing is fully traceable. The types of records that build a complete history for each batch include batch production records, logbooks, raw material and packaging records, and laboratory control records. Together, these documents let investigators reconstruct exactly what happened during production, who did it, and whether it met specifications.
Many facilities are shifting from paper-based records to electronic batch records, which guide operators through manufacturing steps, capture data automatically, and maintain audit trails with electronic signatures and secure access logs. These digital systems reduce the risk of human transcription errors and give quality teams real-time visibility into production progress. They must comply with specific regulations governing electronic records, which set standards for data integrity, system validation, and access controls.
Premises
Premises refers to the physical facilities and equipment where manufacturing takes place. Facility design matters more than most people realize. The FDA advises companies to carefully evaluate their manufacturing processes when designing or modifying a facility, optimizing the flow of materials, equipment, and people to prevent contamination. A poorly designed layout, where raw materials cross paths with finished products or where airflow carries particles between rooms, creates contamination risks that no amount of cleaning can fully address.
Equipment must be designed to facilitate both its intended use and its cleaning and maintenance. Calibration is an ongoing obligation. For something as straightforward as a scale, performance checks should happen on a regular schedule based on how often the scale is used and how critical the measurement is. Even scales with built-in auto-calibration features need external verification, typically once a year, using nationally traceable standards.
Cross-contamination control is a major focus. While regulations don’t always require dedicated equipment for every product, manufacturers working with potent compounds must identify the risks and define controls to eliminate cross-contamination. Those controls include validated cleaning methods and contaminant monitoring. All equipment must be cleaned, maintained, and, where appropriate, sanitized or sterilized at intervals that prevent any compromise to product safety, identity, strength, quality, or purity.
How These Components Work Together
The 5 Ps are not independent checkboxes. They function as an interlocking system. Well-trained people follow documented procedures to run validated processes inside properly maintained premises, producing products that meet defined specifications. A failure in one area cascades into others. Poorly written SOPs lead to inconsistent processes. Undertrained staff misuse equipment. Contaminated premises compromise otherwise sound products.
Regulatory inspectors evaluate all five components during facility inspections. When they find violations, they document them on an FDA Form 483, which lists the specific conditions or practices that suggest a product may not meet requirements. These observations can lead to warning letters, import restrictions, or in serious cases, product recalls and facility shutdowns. The inspection framework used by regulators around the world, including the WHO and the EU, mirrors this same five-pillar structure, making it the universal language of manufacturing quality regardless of where a facility operates.